Oral Contraceptive Pills Market: By Drug Type, By Distribution Channel, and Region Forecast 2020-2031  

Oral Contraceptive Pills Market Size, Share, Growth, Trends, and Global Industry Analysis: By Drug Type (Progestin Only Pills, Combination Pills, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region Forecast 2020-2031  

Oral Contraceptive Pills Market size was valued at US$ 16.7 billion in 2024 and is poised to grow at a CAGR of 5.8% from 2025-2031. The oral contraceptive pills or birth control pills are the medications used to prevent pregnancy. These are hormonal preparations that contain a combination of hormones estrogen and progestin or progestin alone. The mechanism of action of oral contraceptive pills is to prevent pregnancy by inhibiting the follicle-stimulating hormone (FSH) and Luteinizing hormone (LH) which play a major role in egg development and preparation of the lining of the uterus for implantation of an embryo. Contraception is a way of preventing unplanned pregnancies, reducing the risk of sexually transmitted diseases, and controlling the birth rate (STDs).

Furthermore, an increase in the usage of contraception among young women, as well as a rise in educational attainment, help to drive market expansion. Oral pills, injectable contraceptives, and topical contraceptives are all examples of contraception medications. These medicines are used by women of childbearing age between the ages of 15 and 44, following puberty and before menopause. Contraceptive medicines are used by a group of people to avoid pregnancy-transmitted infections (STIs), as well as for birth control and family planning. Some of the primary factors driving the growth of the global contraceptive medicines market include an increase in concerns about family planning and the need to prevent unwanted pregnancies.

Oral Contraceptive Pills Market Summary

Study Period

2025-2031

Base Year

2024

CAGR

5.8%

Largest Market

North-America

Fastest Growing Market

Asia-Pacific

Oral Contraceptive Pills Market Dynamics

Increase in the incidence of unwanted pregnancies is anticipated to drive the global oral contraceptive pills market. Moreover, rise in female population, low cost of oral contraceptive pills, ease of administration, adoption of novel oral contraceptive pills in developed and developing countries, and high effectiveness of the pills are anticipated to propel the global oral contraceptives market. However, stringent regulatory guidelines for the oral contraceptive pills usage, adverse effects associated with the products, religious issues, and poor availability of the products in underdeveloped regions are major restrains of global oral contraceptive pills market over the forecast years.

Oral Contraceptive Pills Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2025-2031

Market Size in 2024

US$ 16.7 billion

Market CAGR

5.8%

By Type

  • Progestin Only Pills
  • Combination Pills
  • Monophasic
  • Triphasic
  • Others
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Key Features of the Report

  • The oral contraceptive pills market report provides granular level information about the market size, regional market share, historic market (2020 to 2024) and forecast (2025 to 2031)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis.

Download Free Sample Report

Frequently Asked Questions

The global oral contraceptive pills market size was valued at US$ 16.7 billion in 2024 and is projected to grow at a CAGR of 5.8% from 2025-2031.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

The Oral Contraceptive Pills Market Key Players are Actavis plc (Allergan plc) (Ireland), Bayer AG (Germany), Merck & Co. Inc. (U.S.), Pfizer, Inc. (U.S.), Teva Pharmaceutical Industries Ltd (Israel)

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Oral Contraceptive Pills Market Introduction 
2.1.Global Oral Contraceptive Pills Market  - Taxonomy
2.2.Global Oral Contraceptive Pills Market  - Definitions
2.2.1.Type
2.2.2.Distribution Channel
2.2.3.Region
3.Global Oral Contraceptive Pills Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Oral Contraceptive Pills Market Analysis, 2020 - 2024 and Forecast 2025 - 2031
4.1.  Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Oral Contraceptive Pills Market  By Type, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
5.1. Progestin Only Pills
5.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Combination Pills
5.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Monophasic
5.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Triphasic
5.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Others
5.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.Global Oral Contraceptive Pills Market  By Distribution Channel, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Online Pharmacies
6.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
7.Global Oral Contraceptive Pills Market  By Region, 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2020 - 2024 and Forecast, 2025 - 2031, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Oral Contraceptive Pills Market 2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
8.1. Type Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Progestin Only Pills
8.1.2.Combination Pills
8.1.3.Monophasic
8.1.4.Triphasic
8.1.5.Others
8.1.6.Others
8.2.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital Pharmacies
8.2.2.Retail Pharmacies
8.2.3.Online Pharmacies
8.3.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Oral Contraceptive Pills Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
9.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Progestin Only Pills
9.1.2.Combination Pills
9.1.3.Monophasic
9.1.4.Triphasic
9.1.5.Others
9.1.6.Others
9.2.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital Pharmacies
9.2.2.Retail Pharmacies
9.2.3.Online Pharmacies
9.3.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Oral Contraceptive Pills Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Progestin Only Pills
10.1.2.Combination Pills
10.1.3.Monophasic
10.1.4.Triphasic
10.1.5.Others
10.1.6.Others
10.2.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital Pharmacies
10.2.2.Retail Pharmacies
10.2.3.Online Pharmacies
10.3.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Oral Contraceptive Pills Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Progestin Only Pills
11.1.2.Combination Pills
11.1.3.Monophasic
11.1.4.Triphasic
11.1.5.Others
11.1.6.Others
11.2.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital Pharmacies
11.2.2.Retail Pharmacies
11.2.3.Online Pharmacies
11.3.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Oral Contraceptive Pills Market ,2020 - 2024 and Forecast 2025 - 2031 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Progestin Only Pills
12.1.2.Combination Pills
12.1.3.Monophasic
12.1.4.Triphasic
12.1.5.Others
12.1.6.Others
12.2.  Distribution Channel Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital Pharmacies
12.2.2.Retail Pharmacies
12.2.3.Online Pharmacies
12.3.  Country Analysis 2020 - 2024 and Forecast 2025 - 2031 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Actavis plc (Ireland)
13.2.2.Bayer AG (Germany)
13.2.3.Merck & Co. Inc. (U.S.)
13.2.4.Pfizer, Inc. (U.S.)
13.2.5.Teva Pharmaceutical Industries Ltd (Israel)
13.2.6.Church & Dwight Co, Inc. (U.S)
13.2.7.Mylan N.V. (U.S.)
13.2.8.Novartis AG (Switzerland)
13.2.9.Piramal Enterprises Limited (India)
14. Research Methodology 
15. Appendix and Abbreviations 

Key Market Players

  • Actavis plc (Ireland)
  • Bayer AG (Germany)
  • Merck & Co. Inc. (U.S.)
  • Pfizer, Inc. (U.S.)
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Church & Dwight Co, Inc. (U.S)
  • Mylan N.V. (U.S.)
  • Novartis AG (Switzerland)
  • Piramal Enterprises Limited (India)

Related Industry Reports